Collecting blood and tissue from patients with liver cancer
Part of Cancer, Digestive system clinical trials.
This study collects blood and tumor tissue samples from people with primary liver cancer who are starting their first treatment (systemic therapy or surgery). The samples help researchers learn more about these cancers and how to improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary liver cancer (either hepatocellular carcinoma or intrahepatic cholangiocarcinoma).
- You are about to start your first systemic therapy (like pills or infusions) OR are scheduled for surgery to remove the tumor.
- You can sign a consent form agreeing to donate blood and tumor tissue samples for research.
- You do not have another active cancer (except certain treated skin cancers or early-stage cancers with no recurrence).
- You do not have an autoimmune or chronic inflammatory disease, HIV, or ongoing substance abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
This study collects and stores blood or tissue samples and medical information from people with liver, bile duct, gallbladder, or pancreatic conditions (including cancer) to help future research. By joining, you help scientists better understand these diseases and develop new treatments.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This study is looking for people with or without liver cancer to test a new way to find liver cancer early using blood or tissue samples. It aims to help catch the disease sooner.
This study collects tumor samples and medical information from patients with liver cancer to understand why some patients respond better to immunotherapy (immune-boosting drugs) than others. The goal is to improve treatment selection and outcomes for future patients.
This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.